Lifecore Biomedical, Inc.

NASDAQ:LFCR

Drug Manufacturers - Specialty & Generic

Healthcare
$6.40 +0.27%

+$0.02 today

Market cap
$242.60M
Beta
1.07
P/E (TTM)
-6.1
EPS (TTM)
-$0.91
52W Low $3.63High $8.98

Volume 0.15M

Average 0.29M

LFCR Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Lifecore Biomedical, Inc.NASDAQ: LFCR

Accumulated OCI · Q4 FY2026 · quarter ended Dec 2025

Accumulated OCI of $0 in Q4 FY2026

Q4 FY2026 Accumulated OCI was $0.

Context

  • Accumulated OCI amounted to 0.0% of total assets at the end of Q4 FY2026.
  • Accumulated OCI increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2026
0 USD
Year-over-year change
—

Accumulated OCI vs competitors

How LFCR compares with its peers on the latest reported figures

  • Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
  • Accumulated OCI amounts to 0.0% of total assets for LFCR, versus a peer median of 0.2%.
LFCR Competitors
Accumulated OCI for LFCR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IMMPImmutep LimitedDec 2025A$47.26M AUD+7.2%+22.0%32.1%
PRQRProQR Therapeutics N.V.Mar 2026€28.33M EUR-2.8%-1.8%28.6%
CGCCanopy Growth CorporationMar 2026CA$10.53M CAD+1868.2%—0.9%
BIOABioAge Labs, Inc.Mar 2026$73K USD-72.3%+18.5%0.0%
ACHVAchieve Life Sciences, Inc.Mar 2026$2K USD-66.7%+35.7%0.0%
LFCRLifecore Biomedical, Inc.Dec 2025$0 USD——0.0%
SGHTSight Sciences, Inc.Mar 2026$0 USD——0.0%
TKNOAlpha Teknova, Inc.Mar 2026$0 USD——0.0%
CVRXCVRx, Inc.Mar 2026-$203K USD+1.0%—0.2%
ACBAurora Cannabis Inc.Mar 2026-CA$214.15M CAD-283.0%—35.5%
Peer median (excluding LFCR) —-2.8%+20.2%0.2%

Competitors are the stored peer set for LFCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
Dec 2025
Cash & Equivalents991K19.09M8.46M8.27M17.47M
Short-term Investments00000
Net Receivables38.31M29.02M31.15M43.67M33.82M
Inventory36M40.84M39.98M32.29M29.09M
Other Current Assets34.31M4.92M1.44M1.45M1.92M
Total Current Assets116.67M93.88M81.03M85.68M82.29M
Property, Plant & Equipment (Net)124.22M138.67M149.17M129.01M127.3M
Goodwill13.88M13.88M13.88M13.88M13.88M
Intangible Assets4.2M4.2M4.2M4.2M0
Long-term Investments00000
Tax Assets00000
Other Non-current Assets15.73M2.92M5.68M6.58M8.7M
Total Non-current Assets158.04M159.67M172.93M153.67M149.89M
Total Assets274.7M253.55M253.96M239.34M232.18M
Account Payables12.95M22.1M16.33M8.22M5.84M
Short-term Debt138.18M580K943K3.44M773K
Tax Payables00000
Deferred Revenue919K4.06M2.11M3.42M8.66M
Other Current Liabilities13.69M4.15M8.54M8.31M6.05M
Total Current Liabilities176.58M39.29M38.87M30.18M23.57M
Long-term Debt97.58M101.07M123.73M127M135.59M
Deferred Tax Liabilities126K380K543K00
Deferred Revenue (Non-current)02.94M4.7M00
Other Non-current Liabilities(95.06M)104.39M69.86M80.83M81.52M
Total Non-current Liabilities10.3M218.49M203.77M207.83M222.81M
Total Liabilities186.88M257.78M242.65M238.01M246.38M
Common Stock30K30K31K37K37K
Retained Earnings(78.97M)(178.54M)(166.52M)(205.24M)(223.2M)
Accumulated OCI(586K)0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity87.82M(4.23M)11.32M1.34M(14.2M)
Total Debt247.78M112.62M133.58M130.82M142.61M
Net Debt246.79M93.53M125.11M122.56M125.14M

Lifecore Biomedical, Inc.

NASDAQ:LFCR

Intrinsic Alpha fair value

Locked

Current Price

$6.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.